Fedorchuk K, Russell S, Zibaei K, Yassin M, Hicks D
PLoS One. 2025; 20(2):e0315947.
PMID: 39928591
PMC: 11809811.
DOI: 10.1371/journal.pone.0315947.
Alanazi A, Barui A, Mohieldin A, Gupta A, Ramchandran R, Nauli S
Front Cell Dev Biol. 2024; 12:1397931.
PMID: 39268086
PMC: 11390542.
DOI: 10.3389/fcell.2024.1397931.
Huang C, Yang X, Li H, Zhang L, Guo Q, Yu Q
J Nanobiotechnology. 2024; 22(1):542.
PMID: 39238020
PMC: 11378416.
DOI: 10.1186/s12951-024-02813-w.
Chen Q, Xiao H, Hu L, Huang Y, Cao Z, Shuai X
Adv Sci (Weinh). 2024; 11(36):e2401182.
PMID: 39051482
PMC: 11423248.
DOI: 10.1002/advs.202401182.
McDaniels J, Shetty A, Rousselle T, Bardhi E, Maluf D, Mas V
Front Transplant. 2024; 1:988238.
PMID: 38994377
PMC: 11235379.
DOI: 10.3389/frtra.2022.988238.
Monitoring Cell Proliferation by Dye Dilution: Considerations for Panel Design.
Tario Jr J, Soh K, Wallace P, Muirhead K
Methods Mol Biol. 2024; 2779:159-216.
PMID: 38526787
DOI: 10.1007/978-1-0716-3738-8_9.
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy.
Zhang Z, Xu X, du J, Chen X, Xue Y, Zhang J
Nat Commun. 2024; 15(1):1118.
PMID: 38320994
PMC: 10847518.
DOI: 10.1038/s41467-024-44963-3.
Inosine induces stemness features in CAR-T cells and enhances potency.
Klysz D, Fowler C, Malipatlolla M, Stuani L, Freitas K, Chen Y
Cancer Cell. 2024; 42(2):266-282.e8.
PMID: 38278150
PMC: 10923096.
DOI: 10.1016/j.ccell.2024.01.002.
A mean-field description for the expansion kinetics of activated T cell populations.
Straube R, Schmidt B
Proc Natl Acad Sci U S A. 2023; 120(45):e2305774120.
PMID: 37910551
PMC: 10636355.
DOI: 10.1073/pnas.2305774120.
Picking up speed: cell cycle regulation during effector CD8 T cell differentiation.
Kretschmer L, Fuchs N, Busch D, Buchholz V
Med Microbiol Immunol. 2023; 212(3):253-260.
PMID: 37277539
PMC: 10293348.
DOI: 10.1007/s00430-023-00768-7.
Bacterial Metabolism-Initiated Nanocatalytic Tumor Immunotherapy.
Wu W, Pu Y, Gao S, Shen Y, Zhou M, Yao H
Nanomicro Lett. 2022; 14(1):220.
PMID: 36367591
PMC: 9652197.
DOI: 10.1007/s40820-022-00951-0.
Systems-level identification of key transcription factors in immune cell specification.
Liu C, Omilusik K, Toma C, Kurd N, Chang J, Goldrath A
PLoS Comput Biol. 2022; 18(9):e1010116.
PMID: 36156073
PMC: 9536753.
DOI: 10.1371/journal.pcbi.1010116.
Alpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy/chemodynamic therapy to discourage cancer progression.
Zhang J, Li F, Yin Y, Liu N, Zhu M, Zhang H
Biomater Res. 2022; 26(1):44.
PMID: 36076298
PMC: 9461185.
DOI: 10.1186/s40824-022-00290-6.
CD8 memory precursor cell generation is a continuous process.
Todorov H, Prieux M, Laubreton D, Bouvier M, Wang S, de Bernard S
iScience. 2022; 25(9):104927.
PMID: 36065187
PMC: 9440290.
DOI: 10.1016/j.isci.2022.104927.
Divide and Conquer: Phenotypic and Temporal Heterogeneity Within CD8 T Cell Responses.
Richard A
Front Immunol. 2022; 13:949423.
PMID: 35911755
PMC: 9334874.
DOI: 10.3389/fimmu.2022.949423.
Mapping CAR T-Cell Design Space Using Agent-Based Models.
Prybutok A, Yu J, Leonard J, Bagheri N
Front Mol Biosci. 2022; 9:849363.
PMID: 35903149
PMC: 9315201.
DOI: 10.3389/fmolb.2022.849363.
Short and long-term immune changes in different severity groups of COVID-19 disease.
Al Maamari K, Al Busaidi I, Al Kindi M, Zadjali F, BaAlawi F, Anesta W
Int J Infect Dis. 2022; 122:776-784.
PMID: 35840099
PMC: 9284586.
DOI: 10.1016/j.ijid.2022.07.026.
Counting generations in birth and death processes with competing Erlang and exponential waiting times.
Belluccini G, Lopez-Garcia M, Lythe G, Molina-Paris C
Sci Rep. 2022; 12(1):11289.
PMID: 35789162
PMC: 9253354.
DOI: 10.1038/s41598-022-14202-0.
Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy.
Jenner A, Smalley M, Goldman D, Goins W, Cobbs C, Puchalski R
iScience. 2022; 25(6):104395.
PMID: 35637733
PMC: 9142563.
DOI: 10.1016/j.isci.2022.104395.
Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy.
Luo J, Wang X, Shi Z, Zeng Y, He L, Cao J
J Nanobiotechnology. 2022; 20(1):228.
PMID: 35568916
PMC: 9107704.
DOI: 10.1186/s12951-022-01453-2.